Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 629

    2.

    Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

    Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P.

    Diabetes. 2000 Mar;49(3):476-84.PMID: 10868971 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

    Diabet Med. 2004 Nov;21(11):1192-9.PMID: 15498085 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

    Ahmad J, Siddiqui MA, Ahmad H.

    Diabetes Care. 1997 Oct;20(10):1576-81.PMID: 9314638 [PubMed - indexed for MEDLINE]Related articles

    6.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

    Kidney Int. 2000 Feb;57(2):590-600.PMID: 10652036 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.

    Ahmad J, Shafique S, Abidi SM, Parwez I.

    Diabetes Res Clin Pract. 2003 May;60(2):131-8.PMID: 12706322 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.

    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.

    Am J Kidney Dis. 2001 May;37(5):890-9.PMID: 11325669 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.

    Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R.

    Diabetes. 1996 Feb;45(2):216-22.PMID: 8549868 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.

    Rudberg S, Osterby R, Bangstad HJ, Dahlquist G, Persson B.

    Diabetologia. 1999 May;42(5):589-95.PMID: 10333052 [PubMed - indexed for MEDLINE]Related articles

    14.

    Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.

    Jerums G, Allen TJ, Gilbert RE, Hammond J, Cooper ME, Campbell DJ, Raffaele J.

    J Diabetes Complications. 1995 Oct-Dec;9(4):308-14. Review.PMID: 8573754 [PubMed - indexed for MEDLINE]Related articles

    15.

    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.

    Kidney Int. 2001 Jul;60(1):277-83.PMID: 11422762 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.

    Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH.

    Kidney Int. 2000 Feb;57(2):601-6.PMID: 10652037 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.

    Ann Intern Med. 1998 Jun 15;128(12 Pt 1):982-8.PMID: 9625684 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.

    Heinemann L, Janicke I, Bender R, Berger M, Sawicki PT.

    Horm Metab Res. 1996 Oct;28(10):549-52.PMID: 8934214 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

    Clin Ther. 2008 Mar;30(3):482-98.PMID: 18405787 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data